{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:26:14Z","timestamp":1793489174478,"version":"4.5.0"},"reference-count":153,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Poly(ethylene glycol) (PEG) has been widely applied in biomedical field as a gold standard. The conjugation of PEG to proteins, peptides, oligonucleotides (DNA, small interfering RNA (siRNA), microRNA (miRNA)) and nanoparticles, also known as PEGylation, is a common method to improve the efficiency of drug delivery and pharmacokinetics in vivo. The effect of PEGylation on the in vivo fate of various formulations has been and continues to be extensively studied based on the successful PEGylation of proteins to improve in vivo circulation time and reduce immunogenicity. The PEG shell protects the particles from aggregation, immune recognition, and phagocytosis, thereby prolonging the in vivo circulation time. This article mainly describes the development background, advantages and applications of PEGylation in the field of drug delivery, its defects or development bottlenecks, and possible alternatives.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867329666220929152644","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:08:57Z","timestamp":1664521737000},"page":"1386-1405","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Achievements and Bottlenecks of PEGylation in Nano-delivery\nSystems"],"prefix":"10.2174","volume":"30","author":[{"given":"Ruoyu","family":"Shen","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou, 310058,\nZhejiang Province, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou, 310058,\nZhejiang Province, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","volume":"40","author":"Harris J.M.","year":"2001","unstructured":"Harris J.M.; Martin N.E.; Modi M.; Pegylation. Clin Pharmacokinet 2001,40(7),539-551","journal-title":"Clin Pharmacokinet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"Harris J.M.","year":"2003","unstructured":"Harris J.M.; Chess R.B.; Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003,2(3),214-221","journal-title":"Nat Rev Drug Discov"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/09205063.2020.1825304","volume":"32","author":"Yadav D.","year":"2021","unstructured":"Yadav D.; Dewangan H.K.; PEGYLATION: an important approach for novel drug delivery system. J Biomater Sci Polym Ed 2021,32(2),266-280","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","volume":"10","author":"Veronese F.M.","year":"2005","unstructured":"Veronese F.M.; Pasut G.; PEGylation, successful approach to drug delivery. Drug Discov Today 2005,10(21),1451-1458","journal-title":"Drug Discov Today"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1039\/C2BM00121G","volume":"1","author":"Br&#xE9; L.P.","year":"2013","unstructured":"Br&#xE9; L.P.; Zheng Y.; P&#xEA;go A.P.; Wang W.; Taking tissue adhesives to the future: from traditional synthetic to new biomimetic approaches. Biomater Sci 2013,1(3),239-253","journal-title":"Biomater Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"Suk J.S.","year":"2016","unstructured":"Suk J.S.; Xu Q.; Kim N.; Hanes J.; Ensign L.M.; PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 2016,99(Pt A),28-51","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1039\/c1py00034a","volume":"2","author":"Alconcel S.N.S.","year":"2011","unstructured":"Alconcel S.N.S.; Baas A.S.; Maynard H.D.; FDA-approved poly(ethylene glycol)\u2013protein conjugate drugs. Polym Chem 2011,2(7),1442-1448","journal-title":"Polym Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.2147\/IJN.S273713","volume":"15","author":"Sebak A.A.","year":"2020","unstructured":"Sebak A.A.; Gomaa I.E.O.; ElMeshad A.N.; Farag M.H.; Breitinger U.; Breitinger H.G.; AbdelKader M.H.; Distinct proteins in protein corona of nanoparticles represent a promising venue for endogenous targeting \u2013 Part I: In vitro release and intracellular uptake perspective. Int J Nanomedicine 2020,15,8845-8862","journal-title":"Int J Nanomedicine"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0169-409X(02)00021-2","volume":"54","author":"Davis F.F.","year":"2002","unstructured":"Davis F.F.; The origin of pegnology. Adv Drug Deliv Rev 2002,54(4),457-458","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","volume":"252","author":"Abuchowski A.","year":"1977","unstructured":"Abuchowski A.; McCoy J.R.; Palczuk N.C.; van Es T.; Davis F.F.; Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977,252(11),3582-3586","journal-title":"J Biol Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0169-409X(02)00020-0","volume":"54","author":"Veronese F.M.","year":"2002","unstructured":"Veronese F.M.; Harris J.M.; Introduction and overview of peptide and protein pegylation. Adv Drug Deliv Rev 2002,54(4),453-456","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=12","first-page":"249","volume":"9","author":"Delgado C.","year":"1992","unstructured":"Delgado C.; Francis G.E.; Fisher D.; The uses and properties of PEG-linked proteins. Crit Rev Ther Drug Carrier Syst 1992,9(3-4),249-304","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJM198703053161005","volume":"316","author":"Hershfield M.S.","year":"1987","unstructured":"Hershfield M.S.; Buckley R.H.; Greenberg M.L.; Melton A.L.; Schiff R.; Hatem C.; Kurtzberg J.; Markert M.L.; Kobayashi R.H.; Kobayashi A.L.; Abuchowski A.; Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 1987,316(10),589-596","journal-title":"N Engl J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000235318","volume":"94","author":"Sehon A.H.","year":"1991","unstructured":"Sehon A.H.; Carl Prausnitz Memorial Lecture. Suppression of antibody responses by chemically modified antigens. Int Arch Allergy Immunol 1991,94(1-4),11-20","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0167-7799(97)84203-5","volume":"15","author":"Okahata Y.","year":"1997","unstructured":"Okahata Y.; Mori T.; Lipid-coated enzymes as efficient catalysts in organic media. Trends Biotechnol 1997,15(2),50-54","journal-title":"Trends Biotechnol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1002\/anie.200902672","volume":"49","author":"Knop K.","year":"2010","unstructured":"Knop K.; Hoogenboom R.; Fischer D.; Schubert U.S.; Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed 2010,49(36),6288-6308","journal-title":"Angew Chem Int Ed"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","volume":"105","author":"Turecek P.L.","year":"2016","unstructured":"Turecek P.L.; Bossard M.J.; Schoetens F.; Ivens I.A.; PEGylation of biopharmaceuticals: A review of chemistry and nonclinical safety information of approved drugs. J Pharm Sci 2016,105(2),460-475","journal-title":"J Pharm Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6163904","volume":"2020","author":"Mej&#xED;a-Manzano L.A.","year":"2020","unstructured":"Mej&#xED;a-Manzano L.A.; V&#xE1;zquez-Villegas P.; Gonz&#xE1;lez-Valdez J.; Perspectives, tendencies, and guidelines in affinity-based strategies for the recovery and purification of PEGylated proteins. Adv Polym Technol 2020,2020(2),1-12","journal-title":"Adv Polym Technol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2020.05.013","volume":"158","author":"Hoffman A.S.","year":"2020","unstructured":"Hoffman A.S.; Lai J.J.; Three significant highlights of controlled drug delivery over the past 55 years: PEGylation, ADCs, and EPR. Adv Drug Deliv Rev 2020,158,2-3","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=20","first-page":"388","volume":"30","author":"Peters B.G.","year":"1995","unstructured":"Peters B.G.; Goeckner B.J.; Ponzillo J.J.; Velasquez W.S.; Wilson A.L.; Pegaspargase versus asparaginase in adult ALL: a pharmacoeconomic assessment. Formulary 1995,30(7),388-393","journal-title":"Formulary"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"Ekladious I.","year":"2019","unstructured":"Ekladious I.; Colson Y.L.; Grinstaff M.W.; Polymer\u2013drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov 2019,18(4),273-294","journal-title":"Nat Rev Drug Discov"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","volume":"54","author":"Roberts M.J.","year":"2002","unstructured":"Roberts M.J.; Bentley M.D.; Harris J.M.; Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002,54(4),459-476","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/s41565-019-0568-x","volume":"14","author":"Ram&#xED;rez-Garc&#xED;a P.D.","year":"2019","unstructured":"Ram&#xED;rez-Garc&#xED;a P.D.; Retamal J.S.; Shenoy P.; Imlach W.; Sykes M.; Truong N.; Constandil L.; Pelissier T.; Nowell C.J.; Khor S.Y.; Layani L.M.; Lumb C.; Poole D.P.; Lieu T.; Stewart G.D.; Mai Q.N.; Jensen D.D.; Latorre R.; Scheff N.N.; Schmidt B.L.; Quinn J.F.; Whittaker M.R.; Veldhuis N.A.; Davis T.P.; Bunnett N.W.; A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain. Nat Nanotechnol 2019,14(12),1150-1159","journal-title":"Nat Nanotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/ncomms2905","volume":"4","author":"Truong N.P.","year":"2013","unstructured":"Truong N.P.; Gu W.; Prasadam I.; Jia Z.; Crawford R.; Xiao Y.; Monteiro M.J.; An influenza virus-inspired polymer system for the timed release of siRNA. Nat Commun 2013,4(1),1902","journal-title":"Nat Commun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1039\/C5PY01467K","volume":"7","author":"Truong N.P.","year":"2016","unstructured":"Truong N.P.; Whittaker M.R.; Anastasaki A.; Haddleton D.M.; Quinn J.F.; Davis T.P.; Facile production of nanoaggregates with tuneable morphologies from thermoresponsive P(DEGMA-co-HPMA). Polym Chem 2016,7(2),430-440","journal-title":"Polym Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1801702","DOI":"10.1002\/smll.201801702","volume":"14","author":"Khor S.Y.","year":"2018","unstructured":"Khor S.Y.; Vu M.N.; Pilkington E.H.; Johnston A.P.R.; Whittaker M.R.; Quinn J.F.; Truong N.P.; Davis T.P.; Elucidating the influences of size, surface chemistry, and dynamic flow on cellular association of nanoparticles made by polymerization-induced self-assembly. Small 2018,14(34),1801702","journal-title":"Small"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/17425247.2017.1316262","volume":"15","author":"Ta H.T.","year":"2018","unstructured":"Ta H.T.; Truong N.P.; Whittaker A.K.; Davis T.P.; Peter K.; The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases. Expert Opin Drug Deliv 2018,15(1),33-45","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1800438","DOI":"10.1002\/marc.201800438","volume":"40","author":"Khor S.Y.","year":"2019","unstructured":"Khor S.Y.; Quinn J.F.; Whittaker M.R.; Truong N.P.; Davis T.P.; Controlling nanomaterial size and shape for biomedical applications via polymerization-induced self-assembly. Macromol Rapid Commun 2019,40(2),1800438","journal-title":"Macromol Rapid Commun"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1021\/acsmacrolett.7b00978","volume":"7","author":"Truong N.P.","year":"2018","unstructured":"Truong N.P.; Zhang C.; Nguyen T.A.H.; Anastasaki A.; Schulze M.W.; Quinn J.F.; Whittaker A.K.; Hawker C.J.; Whittaker M.R.; Davis T.P.; Overcoming surfactant-induced morphology instability of noncrosslinked diblock copolymer nano-objects obtained by RAFT emulsion polymerization. ACS Macro Lett 2018,7(2),159-165","journal-title":"ACS Macro Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/10408398.2016.1160363","volume":"58","author":"Jain A.","year":"2018","unstructured":"Jain A.; Ranjan S.; Dasgupta N.; Ramalingam C.; Nanomaterials in food and agriculture: An overview on their safety concerns and regulatory issues. Crit Rev Food Sci Nutr 2018,58(2),297-317","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1158\/1078-0432.CCR-11-2938","volume":"18","author":"Zamboni W.C.","year":"2012","unstructured":"Zamboni W.C.; Torchilin V.; Patri A.K.; Hrkach J.; Stern S.; Lee R.; Nel A.; Panaro N.J.; Grodzinski P.; Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clin Cancer Res 2012,18(12),3229-3241","journal-title":"Clin Cancer Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1080\/21691401.2019.1604535","volume":"47","author":"Farooq M.A.","year":"2019","unstructured":"Farooq M.A.; Aquib M.; Farooq A.; Haleem Khan D.; Joelle Maviah M.B.; Sied Filli M.; Kesse S.; Boakye-Yiadom K.O.; Mavlyanova R.; Parveen A.; Wang B.; Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artif Cells Nanomed Biotechnol 2019,47(1),1674-1692","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1126\/science.8128245","volume":"263","author":"Gref R.","year":"1994","unstructured":"Gref R.; Minamitake Y.; Peracchia M.T.; Trubetskoy V.; Torchilin V.; Langer R.; Biodegradable long-circulating polymeric nanospheres. Science 1994,263(5153),1600-1603","journal-title":"Science"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.1158\/1078-0432.CCR-05-0343","volume":"11","author":"Laginha K.M.","year":"2005","unstructured":"Laginha K.M.; Verwoert S.; Charrois G.J.R.; Allen T.M.; Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 2005,11(19),6944-6949","journal-title":"Clin Cancer Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/02652049809006831","volume":"15","author":"Torchilin V.P.","year":"1998","unstructured":"Torchilin V.P.; Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul 1998,15(1),1-19","journal-title":"J Microencapsul"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/bc050237q","volume":"17","author":"Baker D.P.","year":"2006","unstructured":"Baker D.P.; Lin E.Y.; Lin K.; Pellegrini M.; Petter R.C.; Chen L.L.; Arduini R.M.; Brickelmaier M.; Wen D.; Hess D.M.; Chen L.; Grant D.; Whitty A.; Gill A.; Lindner D.J.; Pepinsky R.B.; N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model. Bioconjug Chem 2006,17(1),179-188","journal-title":"Bioconjug Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","volume":"244","author":"Zhang P.","year":"2016","unstructured":"Zhang P.; Sun F.; Liu S.; Jiang S.; Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation. J Control Release 2016,244(Pt B),184-193","journal-title":"J Control Release"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1021\/acs.biomac.7b00995","volume":"18","author":"Kaga S.","year":"2017","unstructured":"Kaga S.; Truong N.P.; Esser L.; Senyschyn D.; Sanyal A.; Sanyal R.; Quinn J.F.; Davis T.P.; Kaminskas L.M.; Whittaker M.R.; Influence of size and shape on the biodistribution of nanoparticles prepared by polymerization-induced self-assembly. Biomacromolecules 2017,18(12),3963-3970","journal-title":"Biomacromolecules"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","volume":"124","author":"Huckaby J.T.","year":"2018","unstructured":"Huckaby J.T.; Lai S.K.; PEGylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev 2018,124,125-139","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","volume":"124","author":"Khutoryanskiy V.V.","year":"2018","unstructured":"Khutoryanskiy V.V.; Beyond PEGylation: Alternative surface-modification of nanoparticles with mucus-inert biomaterials. Adv Drug Deliv Rev 2018,124,140-149","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1016\/j.bmc.2017.06.040","volume":"25","author":"Rattan R.","year":"2017","unstructured":"Rattan R.; Bhattacharjee S.; Zong H.; Swain C.; Siddiqui M.A.; Visovatti S.H.; Kanthi Y.; Desai S.; Pinsky D.J.; Goonewardena S.N.; Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting. Bioorg Med Chem 2017,25(16),4487-4496","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10989-019-09840-4","volume":"26","author":"Ramos-de-la-Pe&#xF1;a A.M.","year":"2020","unstructured":"Ramos-de-la-Pe&#xF1;a A.M.; Aguilar O.; Progress and challenges in PEGylated proteins downstream processing: A review of the last 8 years. Int J Pept Res Ther 2020,26(1),333-348","journal-title":"Int J Pept Res Ther"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1517\/14728214.2015.1113254","volume":"20","author":"Swierczewska M.","year":"2015","unstructured":"Swierczewska M.; Lee K.C.; Lee S.; What is the future of PEGylated therapies? Expert Opin Emerg Drugs 2015,20(4),531-536","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/D1NR02065J","volume":"13","author":"Shi L.","year":"2021","unstructured":"Shi L.; Zhang J.; Zhao M.; Tang S.; Cheng X.; Zhang W.; Li W.; Liu X.; Peng H.; Wang Q.; Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale 2021,13(24),10748-10764","journal-title":"Nanoscale"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s40883-021-00198-y","volume":"8","author":"Freire Haddad H.","year":"2022","unstructured":"Freire Haddad H.; Burke J.A.; Scott E.A.; Ameer G.A.; Clinical relevance of pre-existing and treatment-induced Anti-poly(ethylene glycol) antibodies. Regen Eng Transl Med 2022,8(1),32-42","journal-title":"Regen Eng Transl Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.3390\/ma14102577","volume":"14","author":"Raccosta S.","year":"2021","unstructured":"Raccosta S.; Librizzi F.; Jagger A.M.; Noto R.; Martorana V.; Lomas D.A.; Irving J.A.; Manno M.; Scaling concepts in serpin polymer physics. Materials (Basel) 2021,14(10),2577","journal-title":"Materials (Basel)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1051\/jphys:01977003808098300","volume":"38","author":"Alexander S.","year":"1977","unstructured":"Alexander S.; Adsorption of chain molecules with a polar head a scaling description. J Phys (Paris) 1977,38(8),983-987","journal-title":"J Phys (Paris)"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.chemphyslip.2018.12.001","volume":"218","author":"Mahendra A.","year":"2019","unstructured":"Mahendra A.; James H.P.; Jadhav S.; PEG-grafted phospholipids in vesicles: Effect of PEG chain length and concentration on mechanical properties. Chem Phys Lipids 2019,218,47-56","journal-title":"Chem Phys Lipids"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.1016\/j.biomaterials.2014.05.049","volume":"35","author":"Chu M.","year":"2014","unstructured":"Chu M.; Li H.; Wu Q.; Wo F.; Shi D.; Pluronic-encapsulated natural chlorophyll nanocomposites for in vivo cancer imaging and photothermal\/photodynamic therapies. Biomaterials 2014,35(29),8357-8373","journal-title":"Biomaterials"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/acs.biomac.7b01690","volume":"19","author":"Hossain M.D.","year":"2018","unstructured":"Hossain M.D.; Reid J.C.; Lu D.; Jia Z.; Searles D.J.; Monteiro M.J.; Influence of constraints within a cyclic polymer on solution properties. Biomacromolecules 2018,19(2),616-625","journal-title":"Biomacromolecules"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0005-2760(92)90255-T","volume":"1128","author":"Maruyama K.","year":"1992","unstructured":"Maruyama K.; Yuda T.; Okamoto A.; Kojima S.; Suginaka A.; Iwatsuru M.; Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta Lipids Lipid Metab 1992,1128(1),44-49","journal-title":"Biochim Biophys Acta Lipids Lipid Metab"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jcis.2017.05.046","volume":"504","author":"Lin J.","year":"2017","unstructured":"Lin J.; Zhang H.; Morovati V.; Dargazany R.; PEGylation on mixed monolayer gold nanoparticles: Effect of grafting density, chain length, and surface curvature. J Colloid Interface Sci 2017,504,325-333","journal-title":"J Colloid Interface Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1021\/acs.bioconjchem.7b00793","volume":"29","author":"Quach Q.H.","year":"2018","unstructured":"Quach Q.H.; Kong R.L.X.; Kah J.C.Y.; Complement activation by PEGylated gold nanoparticles. Bioconjug Chem 2018,29(4),976-981","journal-title":"Bioconjug Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1021\/ja2084338","volume":"134","author":"Walkey C.D.","year":"2012","unstructured":"Walkey C.D.; Olsen J.B.; Guo H.; Emili A.; Chan W.C.W.; Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 2012,134(4),2139-2147","journal-title":"J Am Chem Soc"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.1021\/acsnano.8b04947","volume":"12","author":"Zhou H.","year":"2018","unstructured":"Zhou H.; Fan Z.; Li P.Y.; Deng J.; Arhontoulis D.C.; Li C.Y.; Bowne W.B.; Cheng H.; Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation. ACS Nano 2018,12(10),10130-10141","journal-title":"ACS Nano"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.apsb.2018.09.001","volume":"9","author":"Liu R.","year":"2019","unstructured":"Liu R.; Hu C.; Yang Y.; Zhang J.; Gao H.; Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 2019,9(2),410-420","journal-title":"Acta Pharm Sin B"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1002\/anie.202012021","volume":"60","author":"Zhao M.","year":"2021","unstructured":"Zhao M.; Wang J.; Lei Z.; Lu L.; Wang S.; Zhang H.; Li B.; Zhang F.; NIR-II pH sensor with a FRET adjustable transition point for in situ dynamic tumor microenvironment visualization. Angew Chem Int Ed 2021,60(10),5091-5095","journal-title":"Angew Chem Int Ed"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1248\/cpb.53.27","volume":"53","author":"Hashizaki K.","year":"2005","unstructured":"Hashizaki K.; Taguchi H.; Itoh C.; Sakai H.; Abe M.; Saito Y.; Ogawa N.; Effects of poly(ethylene glycol) (PEG) concentration on the permeability of PEG-grafted liposomes. Chem Pharm Bull (Tokyo) 2005,53(1),27-31","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1248\/cpb.50.1238","volume":"50","author":"Sriwongsitanont S.","year":"2002","unstructured":"Sriwongsitanont S.; Ueno M.; Physicochemical properties of PEG-grafted liposomes. Chem Pharm Bull (Tokyo) 2002,50(9),1238-1244","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijpharm.2018.04.030","volume":"545","author":"De Leo V.","year":"2018","unstructured":"De Leo V.; Ruscigno S.; Trapani A.; Di Gioia S.; Milano F.; Mandracchia D.; Comparelli R.; Castellani S.; Agostiano A.; Trapani G.; Catucci L.; Conese M.; Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases. Int J Pharm 2018,545(1-2),378-388","journal-title":"Int J Pharm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/polym13071027","volume":"13","author":"De Leo V.","year":"2021","unstructured":"De Leo V.; Milano F.; Agostiano A.; Catucci L.; Recent advancements in polymer\/liposome assembly for drug delivery: From surface modifications to hybrid vesicles. Polymers (Basel) 2021,13(7),1027","journal-title":"Polymers (Basel)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2015.11.003","volume":"221","author":"Lin T.T.","year":"2016","unstructured":"Lin T.T.; Gao D.Y.; Liu Y.C.; Sung Y.C.; Wan D.; Liu J.Y.; Chiang T.; Wang L.; Chen Y.; Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. J Control Release 2016,221,62-70","journal-title":"J Control Release"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"111342","DOI":"10.1016\/j.biopha.2021.111342","volume":"137","author":"Peng W.","year":"2021","unstructured":"Peng W.; Cheng S.; Bao Z.; Wang Y.; Zhou W.; Wang J.; Yang Q.; Chen C.; Wang W.; Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomed Pharmacother 2021,137,111342","journal-title":"Biomed Pharmacother"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.addr.2021.03.020","volume":"173","author":"Richter M.","year":"2021","unstructured":"Richter M.; Vader P.; Fuhrmann G.; Approaches to surface engineering of extracellular vesicles. Adv Drug Deliv Rev 2021,173,416-426","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0014-5793(96)00452-8","volume":"386","author":"Uster P.S.","year":"1996","unstructured":"Uster P.S.; Allen T.M.; Daniel B.E.; Mendez C.J.; Newman M.S.; Zhu G.Z.; Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett 1996,386(2-3),243-246","journal-title":"FEBS Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1021\/acsami.6b14339","volume":"9","author":"Pan Z.","year":"2017","unstructured":"Pan Z.; Fang D.; Song N.; Song Y.; Ding M.; Li J.; Luo F.; Tan H.; Fu Q.; Surface distribution and biophysicochemical properties of polymeric micelles bearing gemini cationic and hydrophilic groups. ACS Appl Mater Interfaces 2017,9(3),2138-2149","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1021\/acsami.5b10675","volume":"8","author":"Chandel A.K.S.","year":"2016","unstructured":"Chandel A.K.S.; Kumar C.U.; Jewrajka S.K.; Effect of polyethylene glycol on properties and drug encapsulation\u2013release performance of biodegradable\/cytocompatible agarose\u2013polyethylene glycol\u2013polycaprolactone amphiphilic Co-Network gels. ACS Appl Mater Interfaces 2016,8(5),3182-3192","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biomaterials.2014.10.036","volume":"38","author":"Miteva M.","year":"2015","unstructured":"Miteva M.; Kirkbride K.C.; Kilchrist K.V.; Werfel T.A.; Li H.; Nelson C.E.; Gupta M.K.; Giorgio T.D.; Duvall C.L.; Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers. Biomaterials 2015,38,97-107","journal-title":"Biomaterials"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ejps.2016.08.058","volume":"93","author":"Lechanteur A.","year":"2016","unstructured":"Lechanteur A.; Furst T.; Evrard B.; Delvenne P.; Hubert P.; Piel G.; PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. Eur J Pharm Sci 2016,93,493-503","journal-title":"Eur J Pharm Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1021\/acs.nanolett.0c02635","volume":"20","author":"Zhu G.","year":"2020","unstructured":"Zhu G.; Xu Z.; Yan L.T.; Entropy at bio-nano interfaces. Nano Lett 2020,20(8),5616-5624","journal-title":"Nano Lett"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nmat2442","volume":"8","author":"Nel A.E.","year":"2009","unstructured":"Nel A.E.; M&#xE4;dler L.; Velegol D.; Xia T.; Hoek E.M.V.; Somasundaran P.; Klaessig F.; Castranova V.; Thompson M.; Understanding biophysicochemical interactions at the nano\u2013bio interface. Nat Mater 2009,8(7),543-557","journal-title":"Nat Mater"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jps.2600840420","volume":"84","author":"Bazile D.","year":"1995","unstructured":"Bazile D.; Prud\u2019homme C.; Bassoullet M.T.; Marlard M.; Spenlehauer G.; Veillard M.; Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 1995,84(4),493-498","journal-title":"J Pharm Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/17435889.3.5.703","volume":"3","author":"Longmire M.","year":"2008","unstructured":"Longmire M.; Choyke P.L.; Kobayashi H.; Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008,3(5),703-717","journal-title":"Nanomedicine (Lond)"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"F579","DOI":"10.1152\/ajprenal.2001.281.4.F579","volume":"281","author":"Deen W.M.","year":"2001","unstructured":"Deen W.M.; Lazzara M.J.; Myers B.D.; Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 2001,281(4),F579-F596","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1016\/S0021-9258(17)40291-2","volume":"252","author":"Abuchowski A.","year":"1977","unstructured":"Abuchowski A.; van Es T.; Palczuk N.C.; Davis F.F.; Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 1977,252(11),3578-3581","journal-title":"J Biol Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"eaay9937","DOI":"10.1126\/sciadv.aay9937","volume":"6","author":"Yang Y.","year":"2020","unstructured":"Yang Y.; Tian F.; Nie D.; Liu Y.; Qian K.; Yu M.; Wang A.; Zhang Y.; Shi X.; Gan Y.; Rapid transport of germ-mimetic nanoparticles with dual conformational polyethylene glycol chains in biological tissues. Sci Adv 2020,6(6),eaay9937","journal-title":"Sci Adv"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12951-021-01100-2","volume":"19","author":"Parodi A.","year":"2021","unstructured":"Parodi A.; Buzaeva P.; Nigovora D.; Baldin A.; Kostyushev D.; Chulanov V.; Savvateeva L.V.; Zamyatnin A.A.; Nanomedicine for increasing the oral bioavailability of cancer treatments. J Nanobiotechnology 2021,19(1),354","journal-title":"J Nanobiotechnology"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ejpb.2012.04.001","volume":"81","author":"Zabaleta V.","year":"2012","unstructured":"Zabaleta V.; Ponchel G.; Salman H.; Ag&#xFC;eros M.; Vauthier C.; Irache J.M.; Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. Eur J Pharm Biopharm 2012,81(3),514-523","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrd1957","volume":"5","author":"Schrama D.","year":"2006","unstructured":"Schrama D.; Reisfeld R.A.; Becker J.C.; Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov 2006,5(2),147-159","journal-title":"Nat Rev Drug Discov"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"102277","DOI":"10.1016\/j.nano.2020.102277","volume":"29","author":"Wang W.","year":"2020","unstructured":"Wang W.; Yan X.; Li Q.; Chen Z.; Wang Z.; Hu H.; Adapted nano-carriers for gastrointestinal defense components: surface strategies and challenges. Nanomedicine 2020,29,102277","journal-title":"Nanomedicine"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2021.11.020","volume":"341","author":"Li J.","year":"2022","unstructured":"Li J.; Qiang H.; Yang W.; Xu Y.; Feng T.; Cai H.; Wang S.; Liu Z.; Zhang Z.; Zhang J.; Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles. J Control Release 2022,341,31-43","journal-title":"J Control Release"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"118760","DOI":"10.1016\/j.carbpol.2021.118760","volume":"275","author":"Xie P.","year":"2022","unstructured":"Xie P.; Liu P.; Chitosan-based DDSs for pH\/hypoxia dual-triggered DOX delivery: Facile morphology modulation for higher in vitro cytotoxicity. Carbohydr Polym 2022,275,118760","journal-title":"Carbohydr Polym"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1517\/17425255.2014.967679","volume":"10","author":"Zhang X.","year":"2014","unstructured":"Zhang X.; Wang H.; Ma Z.; Wu B.; Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns. Expert Opin Drug Metab Toxicol 2014,10(12),1691-1702","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jconrel.2021.11.034","volume":"341","author":"Filipczak N.","year":"2022","unstructured":"Filipczak N.; Joshi U.; Attia S.A.; Berger Fridman I.; Cohen S.; Konry T.; Torchilin V.; Hypoxia-sensitive drug delivery to tumors. J Control Release 2022,341,431-442","journal-title":"J Control Release"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/acsami.1c21828","volume":"14","author":"Zhang M.","year":"2022","unstructured":"Zhang M.; Jia C.; Zhuang J.; Hou Y.Y.; He X.W.; Li W.Y.; Bai G.; Zhang Y.K.; GSH-responsive drug delivery system for active therapy and reducing the side effects of bleomycin. ACS Appl Mater Interfaces 2022,14(1),417-427","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"132107","DOI":"10.1016\/j.cej.2021.132107","volume":"428","author":"Hu S.","year":"2022","unstructured":"Hu S.; Yang Z.; Wang S.; Wang L.; He Q.; Tang H.; Ji P.; Chen T.; Zwitterionic polydopamine modified nanoparticles as an efficient nanoplatform to overcome both the mucus and epithelial barriers. Chem Eng J 2022,428,132107","journal-title":"Chem Eng J"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"114079","DOI":"10.1016\/j.addr.2021.114079","volume":"180","author":"Shi D.","year":"2022","unstructured":"Shi D.; Beasock D.; Fessler A.; Szebeni J.; Ljubimova J.Y.; Afonin K.A.; Dobrovolskaia M.A.; To PEGylate or not to PEGylate: Immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives. Adv Drug Deliv Rev 2022,180,114079","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"100660","DOI":"10.1016\/j.mtchem.2021.100660","volume":"23","author":"Xia X.","year":"2022","unstructured":"Xia X.; Shi J.; Deng Q.; Xu N.; Huang F.; Xiang X.; Biodegradable and self-fluorescent ditelluride-bridged mesoporous organosilica\/polyethylene glycol-curcumin nanocomposite for dual-responsive drug delivery and enhanced therapy efficiency. Mater Today Chem 2022,23,100660","journal-title":"Mater Today Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/pharmaceutics14010039","volume":"14","author":"Reboredo C.","year":"2021","unstructured":"Reboredo C.; Gonz&#xE1;lez-Navarro C.J.; Mart&#xED;nez-L&#xF3;pez A.L.; Mart&#xED;nez-Oh&#xE1;rriz C.; Sarmento B.; Irache J.M.; Zein-based nanoparticles as oral carriers for insulin delivery. Pharmaceutics 2021,14(1),39","journal-title":"Pharmaceutics"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/1381612827666210910104333","volume":"28","author":"Shah N.","year":"2022","unstructured":"Shah N.; Hussain M.; Rehan T.; Khan A.; Khan Z.U.; Overview of polyethylene glycol-based materials with a special focus on core-shell particles for drug delivery application. Curr Pharm Des 2022,28(5),352-367","journal-title":"Curr Pharm Des"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"14739","DOI":"10.1039\/D0NR02291H","volume":"12","author":"Fu Z.","year":"2020","unstructured":"Fu Z.; Williams G.R.; Niu S.; Wu J.; Gao F.; Zhang X.; Yang Y.; Li Y.; Zhu L.M.; Functionalized boron nanosheets as an intelligent nanoplatform for synergistic low-temperature photothermal therapy and chemotherapy. Nanoscale 2020,12(27),14739-14750","journal-title":"Nanoscale"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"112261","DOI":"10.1016\/j.colsurfb.2021.112261","volume":"210","author":"Ye Y.","year":"2022","unstructured":"Ye Y.; Bremner D.H.; Zhang H.; Chen X.; Lou J.; Zhu L.M.; Functionalized layered double hydroxide nanoparticles as an intelligent nanoplatform for synergistic photothermal therapy and chemotherapy of tumors. Colloids Surf B Biointerfaces 2022,210,112261","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s13205-021-03105-y","volume":"12","author":"Mundel R.","year":"2022","unstructured":"Mundel R.; Thakur T.; Chatterjee M.; Emerging uses of PLA-PEG copolymer in cancer drug delivery. 3 Biotech 2022,12(2),41","journal-title":"3 Biotech"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10876-021-02217-y","volume":"2022","author":"Dadashpour M.","year":"2022","unstructured":"Dadashpour M.; Ganjibakhsh M.; Mousazadeh H.; Nejati K.; Increased pro-apoptotic and anti-proliferative activities of simvastatin encapsulated PCL-PEG nanoparticles on human breast cancer adenocarcinoma cells. J Clust Sci 2022,2022,1-12","journal-title":"J Clust Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s13346-021-01112-3","volume":"12","author":"Sim&#xF3;n-V&#xE1;zquez R.","year":"2022","unstructured":"Sim&#xF3;n-V&#xE1;zquez R.; Tsapis N.; Lorscheider M.; Rodr&#xED;guez A.; Calleja P.; Mousnier L.; de Miguel Villegas E.; Gonz&#xE1;lez-Fern&#xE1;ndez &#xC1;.; Fattal E.; Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles. Drug Deliv Transl Res 2022,12(5),1270-1284","journal-title":"Drug Deliv Transl Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/diagnostics12010173","volume":"12","author":"Guido C.","year":"2022","unstructured":"Guido C.; Baldari C.; Maiorano G.; Mastronuzzi A.; Carai A.; Quintarelli C.; De Angelis B.; Cortese B.; Gigli G.; Palam&#xE0; I.E.; Nanoparticles for diagnosis and target therapy in pediatric brain cancers. Diagnostics (Basel) 2022,12(1),173","journal-title":"Diagnostics (Basel)"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/polym14020227","volume":"14","author":"Dardeer H.M.","year":"2022","unstructured":"Dardeer H.M.; Toghan A.; Zaki M.E.A.; Elamary R.B.; Design, synthesis and evaluation of novel antimicrobial polymers based on the inclusion of polyethylene Glycol\/TiO nanocomposites in cyclodextrin as drug carriers for sulfaguanidine. Polymers (Basel) 2022,14(2),227","journal-title":"Polymers (Basel)"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1021\/acsami.8b18843","volume":"11","author":"Abstiens K.","year":"2019","unstructured":"Abstiens K.; Gregoritza M.; Goepferich A.M.; Ligand density and linker length are critical factors for multivalent nanoparticle\u2013receptor interactions. ACS Appl Mater Interfaces 2019,11(1),1311-1320","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"118507","DOI":"10.1016\/j.ijpharm.2019.118507","volume":"568","author":"Jia T.","year":"2019","unstructured":"Jia T.; Ciccione J.; Jacquet T.; Maurel M.; Montheil T.; Mehdi A.; Martinez J.; Eymin B.; Subra G.; Coll J.L.; The presence of PEG on nanoparticles presenting the c[RGDfK]- and\/or ATWLPPR peptides deeply affects the RTKs-AKT-GSK3&#x3B2;-eNOS signaling pathway and endothelial cells survival. Int J Pharm 2019,568,118507","journal-title":"Int J Pharm"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1021\/bm100248e","volume":"11","author":"Wang S.","year":"2010","unstructured":"Wang S.; Dormidontova E.E.; Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations. Biomacromolecules 2010,11(7),1785-1795","journal-title":"Biomacromolecules"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1021\/nn305663e","volume":"7","author":"Stefanick J.F.","year":"2013","unstructured":"Stefanick J.F.; Ashley J.D.; Kiziltepe T.; Bilgicer B.; A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. ACS Nano 2013,7(4),2935-2947","journal-title":"ACS Nano"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1021\/acsami.9b20993","volume":"12","author":"Yong K.W.","year":"2020","unstructured":"Yong K.W.; Yuen D.; Chen M.Z.; Johnston A.P.R.; Engineering the orientation, density, and flexibility of single-domain antibodies on nanoparticles to improve cell targeting. ACS Appl Mater Interfaces 2020,12(5),5593-5600","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1900427","DOI":"10.1002\/mabi.201900427","volume":"20","author":"Maslanka Figueroa S.","year":"2020","unstructured":"Maslanka Figueroa S.; Fleischmann D.; Beck S.; Goepferich A.; The effect of ligand mobility on the cellular interaction of multivalent nanoparticles. Macromol Biosci 2020,20(4),1900427","journal-title":"Macromol Biosci"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1021\/ma012060a","volume":"35","author":"Petersen H.","year":"2002","unstructured":"Petersen H.; Fechner P.M.; Fischer D.; Kissel T.; Synthesis, characterization, and biocompatibility of polyethylenimine- g raft -poly(ethylene glycol) block copolymers. Macromolecules 2002,35(18),6867-6874","journal-title":"Macromolecules"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/138920012798356934","volume":"13","author":"Milla P.","year":"2012","unstructured":"Milla P.; Dosio F.; Cattel L.; PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr Drug Metab 2012,13(1),105-119","journal-title":"Curr Drug Metab"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/bjh.16254","volume":"189","author":"Kloos R.","year":"2020","unstructured":"Kloos R.; Sluis I.M.; Mastrobattista E.; Hennink W.; Pieters R.; Verhoef J.J.; Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker. Br J Haematol 2020,189(3),442-451","journal-title":"Br J Haematol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","volume":"154-155","author":"Kozma G.T.","year":"2020","unstructured":"Kozma G.T.; Shimizu T.; Ishida T.; Szebeni J.; Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv Drug Deliv Rev 2020,154-155,163-175","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","volume":"12","author":"Mima Y.","year":"2015","unstructured":"Mima Y.; Hashimoto Y.; Shimizu T.; Kiwada H.; Ishida T.; Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein. Mol Pharm 2015,12(7),2429-2435","journal-title":"Mol Pharm"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","volume":"19","author":"Verhoef J.J.F.","year":"2014","unstructured":"Verhoef J.J.F.; Carpenter J.F.; Anchordoquy T.J.; Schellekens H.; Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discov Today 2014,19(12),1945-1952","journal-title":"Drug Discov Today"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","volume":"9","author":"Garay R.P.","year":"2012","unstructured":"Garay R.P.; El-Gewely R.; Armstrong J.K.; Garratty G.; Richette P.; Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv 2012,9(11),1319-1323","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.chembiol.2019.02.001","volume":"26","author":"Moreno A.","year":"2019","unstructured":"Moreno A.; Pitoc G.A.; Ganson N.J.; Layzer J.M.; Hershfield M.S.; Tarantal A.F.; Sullenger B.A.; Anti-PEG antibodies inhibit the anticoagulant activity of PEGylated aptamers. Cell Chem Biol 2019,26(5),634-644.e3","journal-title":"Cell Chem Biol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.progpolymsci.2007.05.008","volume":"32","author":"Pasut G.","year":"2007","unstructured":"Pasut G.; Veronese F.M.; Polymer\u2013drug conjugation, recent achievements and general strategies. Prog Polym Sci 2007,32(8-9),933-961","journal-title":"Prog Polym Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/wnan.1339","volume":"7","author":"Yang Q.","year":"2015","unstructured":"Yang Q.; Lai S.K.; Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015,7(5),655-677","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cncr.22739","volume":"110","author":"Armstrong J.K.","year":"2007","unstructured":"Armstrong J.K.; Hempel G.; Koling S.; Chan L.S.; Fisher T.; Meiselman H.J.; Garratty G.; Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer 2007,110(1),103-111","journal-title":"Cancer"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/molecules23071700","volume":"23","author":"Neun B.","year":"2018","unstructured":"Neun B.; Barenholz Y.; Szebeni J.; Dobrovolskaia M.; Understanding the Role of Anti-PEG Antibodies in the complement activation by Doxil in vitro. Molecules 2018,23(7),1700","journal-title":"Molecules"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.jaci.2015.10.034","volume":"137","author":"Ganson N.J.","year":"2016","unstructured":"Ganson N.J.; Povsic T.J.; Sullenger B.A.; Alexander J.H.; Zelenkofske S.L.; Sailstad J.M.; Rusconi C.P.; Hershfield M.S.; Pre-existing anti\u2013polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer. J Allergy Clin Immunol 2016,137(5),1610-1613.e7","journal-title":"J Allergy Clin Immunol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s42004-020-00369-y","volume":"3","author":"Huckaby J.T.","year":"2020","unstructured":"Huckaby J.T.; Jacobs T.M.; Li Z.; Perna R.J.; Wang A.; Nicely N.I.; Lai S.K.; Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers. Commun Chem 2020,3(1),124","journal-title":"Commun Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","volume":"172","author":"Abu Lila A.S.","year":"2013","unstructured":"Abu Lila A.S.; Kiwada H.; Ishida T.; The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage. J Control Release 2013,172(1),38-47","journal-title":"J Control Release"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.xphs.2018.10.027","volume":"108","author":"Wang F.","year":"2019","unstructured":"Wang F.; Ye X.; Wu Y.; Wang H.; Sheng C.; Peng D.; Chen W.; Time interval of two injections and first-dose dependent of accelerated blood clearance phenomenon induced by PEGylated liposomal gambogenic acid: The contribution of PEG-Specific IgM. J Pharm Sci 2019,108(1),641-651","journal-title":"J Pharm Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.ijbiomac.2019.03.046","volume":"131","author":"Qi F.","year":"2019","unstructured":"Qi F.; Qi J.; Hu C.; Shen L.; Yu W.; Hu T.; Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics. Int J Biol Macromol 2019,131,896-904","journal-title":"Int J Biol Macromol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","volume":"9","author":"Hussain Z.","year":"2019","unstructured":"Hussain Z.; Khan S.; Imran M.; Sohail M.; Shah S.W.A.; de Matas M.; PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution. Drug Deliv Transl Res 2019,9(3),721-734","journal-title":"Drug Deliv Transl Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/polym12020298","volume":"12","author":"Hoang Thi T.T.","year":"2020","unstructured":"Hoang Thi T.T.; Pilkington E.H.; Nguyen D.H.; Lee J.S.; Park K.D.; Truong N.P.; The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation. Polymers (Basel) 2020,12(2),298","journal-title":"Polymers (Basel)"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1002\/anie.201814275","volume":"58","author":"Zhang P.","year":"2019","unstructured":"Zhang P.; Jain P.; Tsao C.; Wu K.; Jiang S.; Proactively reducing anti-drug antibodies via immunomodulatory bioconjugation. Angew Chem Int Ed 2019,58(8),2433-2436","journal-title":"Angew Chem Int Ed"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1801177","DOI":"10.1002\/adhm.201801177","volume":"8","author":"Joh D.Y.","year":"2019","unstructured":"Joh D.Y.; Zimmers Z.; Avlani M.; Heggestad J.T.; Aydin H.B.; Ganson N.; Kumar S.; Fontes C.M.; Achar R.K.; Hershfield M.S.; Hucknall A.M.; Chilkoti A.; Architectural modification of conformal PEG-bottlebrush coatings minimizes anti-PEG antigenicity while preserving stealth properties. Adv Healthc Mater 2019,8(8),1801177","journal-title":"Adv Healthc Mater"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"0002","DOI":"10.1038\/s41551-016-0002","author":"Qi Y.","year":"2016","unstructured":"Qi Y.; Simakova A.; Ganson N.J.; Li X.; Luginbuhl K.M.; &#xD6;zer I.; Liu W.; Hershfield M.S.; Matyjaszewski K.; Chilkoti A.; A brush-polymer conjugate of exendin-4 reduces blood glucose for up to five days and eliminates poly(ethylene glycol) antigenicity. Nat Biomed Eng 2016(1),0002","journal-title":"Nat Biomed Eng"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"12004","DOI":"10.1021\/acsnano.8b04314","volume":"12","author":"Li B.","year":"2018","unstructured":"Li B.; Yuan Z.; McMullen P.; Xie J.; Jain P.; Hung H.C.; Xu S.; Zhang P.; Lin X.; Wu K.; Jiang S.; A chromatin-mimetic nanomedicine for therapeutic tolerance induction. ACS Nano 2018,12(12),12004-12014","journal-title":"ACS Nano"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1073\/pnas.1216353110","volume":"110","author":"Kontos S.","year":"2013","unstructured":"Kontos S.; Kourtis I.C.; Dane K.Y.; Hubbell J.A.; Engineering antigens for in situ erythrocyte binding induces T- cell deletion. Proc Natl Acad Sci USA 2013,110(1),E60-E68","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jconrel.2020.10.011","volume":"329","author":"McSweeney M.D.","year":"2021","unstructured":"McSweeney M.D.; Shen L.; DeWalle A.C.; Joiner J.B.; Ciociola E.C.; Raghuwanshi D.; Macauley M.S.; Lai S.K.; Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice. J Control Release 2021,329,774-781","journal-title":"J Control Release"},{"key":"ref=129","first-page":"1071","volume":"292","author":"Dams E.T.","year":"2000","unstructured":"Dams E.T.; Laverman P.; Oyen W.J.; Storm G.; Scherphof G.L.; van Der Meer J.W.; Corstens F.H.; Boerman O.C.; Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 2000,292(3),1071-1079","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","volume":"354","author":"Ishida T.","year":"2008","unstructured":"Ishida T.; Kiwada H.; Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int J Pharm 2008,354(1-2),56-62","journal-title":"Int J Pharm"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","volume":"341","author":"Estap&#xE9; Senti M.","year":"2022","unstructured":"Estap&#xE9; Senti M.; de Jongh C.A.; Dijkxhoorn K.; Verhoef J.J.F.; Szebeni J.; Storm G.; Hack C.E.; Schiffelers R.M.; Fens M.H.; Boross P.; Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. J Control Release 2022,341,475-486","journal-title":"J Control Release"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijpharm.2006.11.018","volume":"331","author":"Romberg B.","year":"2007","unstructured":"Romberg B.; Metselaar J.; Baranyi L.; Snel C.; B&#xFC;nger R.; Hennink W.; Szebeni J.; Storm G.; Poly(amino acid)s: Promising enzymatically degradable stealth coatings for liposomes. Int J Pharm 2007,331(2),186-189","journal-title":"Int J Pharm"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pen.760250302","volume":"25","author":"Porter R.S.","year":"1985","unstructured":"Porter R.S.; Casale A.; Recent studies of polymer reactions caused by stress. Polym Eng Sci 1985,25(3),129-156","journal-title":"Polym Eng Sci"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jconrel.2006.11.004","volume":"117","author":"Lee J.S.","year":"2007","unstructured":"Lee J.S.; Go D.H.; Bae J.W.; Lee S.J.; Park K.D.; Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. J Control Release 2007,117(2),204-209","journal-title":"J Control Release"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0169-409X(91)90007-Y","volume":"7","author":"Larsen N.E.","year":"1991","unstructured":"Larsen N.E.; Balazs E.A.; Drug delivery systems using hyaluronan and its derivatives. Adv Drug Deliv Rev 1991,7(2),279-293","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","volume":"47","author":"Janes K.A.","year":"2001","unstructured":"Janes K.A.; Calvo P.; Alonso M.J.; Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 2001,47(1),83-97","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1016\/j.biomaterials.2009.06.036","volume":"30","author":"Yang W.","year":"2009","unstructured":"Yang W.; Zhang L.; Wang S.; White A.D.; Jiang S.; Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum. Biomaterials 2009,30(29),5617-5621","journal-title":"Biomaterials"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/adma.200901407","volume":"22","author":"Jiang S.","year":"2010","unstructured":"Jiang S.; Cao Z.; Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv Mater 2010,22(9),920-932","journal-title":"Adv Mater"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"8437","DOI":"10.1039\/D1TB01374B","volume":"9","author":"Chiu C.Y.","year":"2021","unstructured":"Chiu C.Y.; Chang Y.; Liu T.H.; Chou Y.N.; Yen T.J.; Convergent charge interval spacing of zwitterionic 4-vinylpyridine carboxybetaine structures for superior blood-inert regulation in amphiphilic phases. J Mater Chem B Mater Biol Med 2021,9(40),8437-8450","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jcis.2021.09.175","volume":"608","author":"Ahmed S.T.","year":"2022","unstructured":"Ahmed S.T.; Leckband D.E.; Forces between mica and end-grafted statistical copolymers of sulfobetaine and oligoethylene glycol in aqueous electrolyte solutions. J Colloid Interface Sci 2022,608(Pt 2),1857-1867","journal-title":"J Colloid Interface Sci"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1021\/acs.nanolett.1c00776","volume":"21","author":"Song Y.","year":"2021","unstructured":"Song Y.; Elsabahy M.; Collins C.A.; Khan S.; Li R.; Hreha T.N.; Shen Y.; Lin Y.N.; Letteri R.A.; Su L.; Dong M.; Zhang F.; Hunstad D.A.; Wooley K.L.; Morphologic design of silver-bearing sugar-based polymer nanoparticles for uroepithelial cell binding and antimicrobial delivery. Nano Lett 2021,21(12),4990-4998","journal-title":"Nano Lett"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1039\/D1PY00815C","volume":"12","author":"Zhao B.","year":"2021","unstructured":"Zhao B.; Yan Y.; Zhang J.; Chen E.; Wang K.; Zhao C.; Zhong Y.; Huang D.; Cui Z.; Deng D.; Gu C.; Chen W.; Synthesis of zwitterionic chimeric polymersomes for efficient protein loading and intracellular delivery. Polym Chem 2021,12(35),5085-5092","journal-title":"Polym Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1039\/c0sm01539c","volume":"7","author":"Oh J.K.","year":"2011","unstructured":"Oh J.K.; Polylactide (PLA)-based amphiphilic block copolymers: synthesis, self-assembly, and biomedical applications. Soft Matter 2011,7(11),5096-5108","journal-title":"Soft Matter"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jconrel.2015.12.015","volume":"240","author":"Cho H.","year":"2016","unstructured":"Cho H.; Gao J.; Kwon G.S.; PEG- b -PLA micelles and PLGA-b-PEG-b-PLGA sol\u2013gels for drug delivery. J Control Release 2016,240,191-201","journal-title":"J Control Release"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/acs.biomac.0c00812","volume":"21","author":"Smith A.A.A.","year":"2020","unstructured":"Smith A.A.A.; Gale E.C.; Roth G.A.; Maikawa C.L.; Correa S.; Yu A.C.; Appel E.A.; Nanoparticles presenting potent TLR7\/8 agonists enhance anti-PD-L1 immunotherapy in cancer treatment. Biomacromolecules 2020,21(9),3704-3712","journal-title":"Biomacromolecules"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/nano10040787","volume":"10","author":"Fam S.Y.","year":"2020","unstructured":"Fam S.Y.; Chee C.F.; Yong C.Y.; Ho K.L.; Mariatulqabtiah A.R.; Tan W.S.; Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials (Basel) 2020,10(4),787","journal-title":"Nanomaterials (Basel)"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/nano9101354","volume":"9","author":"Conte C.","year":"2019","unstructured":"Conte C.; Dal Poggetto G.; J Swartzwelter B.; Esposito D.; Ungaro F.; Laurienzo P.; Boraschi D.; Quaglia F.; Surface exposure of PEG and Amines on biodegradable nanoparticles as a strategy to tune their interaction with protein-rich biological media. Nanomaterials (Basel) 2019,9(10),1354","journal-title":"Nanomaterials (Basel)"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0005-2736(91)90201-I","volume":"1068","author":"Allen T.M.","year":"1991","unstructured":"Allen T.M.; Hansen C.; Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta Biomembr 1991,1068(2),133-141","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","volume":"1066","author":"Allen T.M.","year":"1991","unstructured":"Allen T.M.; Hansen C.; Martin F.; Redemann C.; Yau-Young A.; Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta Biomembr 1991,1066(1),29-36","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1248\/cpb.39.1620","volume":"39","author":"Maruyama K.","year":"1991","unstructured":"Maruyama K.; Yuda T.; Okamoto A.; Ishikura C.; Kojima S.; Iwatsuru M.; Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. Chem Pharm Bull (Tokyo) 1991,39(6),1620-1622","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrc1958","volume":"6","author":"Duncan R.","year":"2006","unstructured":"Duncan R.; Polymer conjugates as anticancer nano- medicines. Nat Rev Cancer 2006,6(9),688-701","journal-title":"Nat Rev Cancer"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/pharmaceutics12060533","volume":"12","author":"Lee H.","year":"2020","unstructured":"Lee H.; Molecular simulations of PEGylated biomolecules, liposomes, and nanoparticles for drug delivery applications. Pharmaceutics 2020,12(6),533","journal-title":"Pharmaceutics"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"10049","DOI":"10.1021\/acsnano.6b04695","volume":"10","author":"Chen Z.","year":"2016","unstructured":"Chen Z.; Zhao P.; Luo Z.; Zheng M.; Tian H.; Gong P.; Gao G.; Pan H.; Liu L.; Ma A.; Cui H.; Ma Y.; Cai L.; Cancer cell membrane\u2013biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano 2016,10(11),10049-10057","journal-title":"ACS Nano"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220929152644","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209312\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220929152644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T16:01:11Z","timestamp":1693670471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209312\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":153,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220929152644","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}